Centene stock holds as guidance stays above $4.80

Published on 09/17/2026 at 11:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Centene stock held near USD 66.05 on September 16, 2026, after management reaffirmed 2026 adjusted EPS above $4.80. The Street sees consensus EPS at $4.89.

Modernes Gesundheitszentrum-Gebäude mit Patienten am Eingang, Außenaufnahme, Tageslicht — Centene Corp. betreibt moderne ambulante Gesundheitszentren in den USA, ISIN US15133V1035 an der NYSE, Illustration mit AI erstellt.

Centene stock (ISIN US15133V1035) traded at USD 66.05 on September 16, 2026, after a 2.38 percent slide, with extended trading at USD 66.03. The move came as Centene Corp. reaffirmed 2026 adjusted diluted EPS guidance above USD 4.80 and GAAP diluted EPS above USD 3.11.

Guidance stays intact

According to StockTitan, Centene said on September 16, 2026 that the Deutsche Bank 2026 Healthcare Summit would be used to reaffirm full-year 2026 guidance, including GAAP diluted EPS above USD 3.11 and adjusted diluted EPS above USD 4.80. The same filing says the guidance is effective only through September 25, 2026.

That puts a clear number on the debate around the shares: the company is still working with an adjusted EPS floor of USD 4.80 for fiscal 2026, while the GAAP floor is USD 3.11. Investors also got a time marker, because the summit presentation was scheduled for September 16, 2026 at 9:00 a.m. EDT.

Consensus sits higher

According to MarketBeat, the stock carried a consensus rating of Hold and an average price target of USD 70.05 on September 17, 2026. In the same market update, The Globe and Mail said Wells Fargo maintained a Hold rating with a USD 69.00 target, while the consensus target stood at USD 72.64.

That leaves Centene below both the USD 69.00 single-target level and the USD 70.05 consensus average cited in those updates. The gap is not large, but it keeps the stock tied to execution on margins rather than a pure rerating story.

Margin focus matters

According to Investing.com, Centene told investors on September 16, 2026 that performance through the first two months of the third quarter was in line with expectations. The same transcript said the company now expects a 93.5 percent health benefit ratio for 2026, a 9 percent year-end membership decline, and 4.5 percent to 5 percent pre-tax margins in ACA.

Those figures frame the risk more clearly than the share price alone. The market is not just reading guidance; it is watching whether Centene can hold the 2026 margin mix while Medicaid membership declines and ACA profitability stays in range.

Stock and valuation

Centene stock closed at USD 66.05 on September 16, 2026, with extended trading at USD 66.03, and MarketBeat put the company's market capitalization at USD 32.63 billion on September 17, 2026. For now, the stock is trading below the USD 69.00 to USD 72.64 target band cited in current market updates.